Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Progyny, Inc. (PGNY)

29.19 +0.79 (+2.78%)
At close: October 30 at 4:00:00 PM EDT
29.19 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade Progyny on Coinbase
Chart Range Bar
Loading chart for PGNY
  • Previous Close 28.40
  • Open 28.66
  • Bid 20.74 x 100
  • Ask 36.44 x 200
  • Day's Range 28.35 - 29.22
  • 52 Week Range 16.10 - 33.06
  • Volume 807,572
  • Avg. Volume 1,100,090
  • Market Cap (intraday) 2.24B
  • Beta (5Y Monthly) 1.02
  • PE Ratio (TTM) 31.73
  • EPS (TTM) 0.92
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 34.42
  • Zacks Rating Neutral

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

www.progyny.com

835

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PGNY
13.67%
S&P 500 (^GSPC)
10.73%

1-Year Return

PGNY
56.51%
S&P 500 (^GSPC)
11.11%

3-Year Return

PGNY
5.87%
S&P 500 (^GSPC)
81.91%

5-Year Return

PGNY
52.48%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 350.51M
Earnings 28.05M
Profit Margin 8.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
100M
200M
300M
4.0%
5.0%
6.0%
7.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

30.00
34.42 Average
29.19 Current
40.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/30/2026
Analyst Wells Fargo
Rating Action Initiated
Rating Overweight
Price Action Announces
Price Target 37

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.00%

  • Return on Assets (ttm)

    10.14%

  • Return on Equity (ttm)

    16.24%

  • Revenue (ttm)

    1.31B

  • Net Income Avi to Common (ttm)

    78.63M

  • Diluted EPS (ttm)

    0.92

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    236.92M

  • Total Debt/Equity (mrq)

    5.95%

  • Levered Free Cash Flow (ttm)

    196.47M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: